2025-03-09 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Review

**0. Key Figures & Initial Analysis:**

* **Cumulative Return (UNH):** 125.52%
* **Cumulative Return (VOO):** 108.62%
* **Return Difference (UNH - VOO):** 16.9%
* **Relative Divergence:** 15.8% (This indicates UNH's outperformance relative to its historical range against VOO.)

UnitedHealth Group Inc. is a diversified healthcare company providing a range of products and services.

**1. Alpha and Beta Analysis:**

The provided data shows UNH exhibiting consistently high CAGR (Compound Annual Growth Rate) over the years, ranging from 32% to 96%, significantly outperforming the market (implied by the positive alpha).  However, the recent periods (2022-2025) show negative CAGR, suggesting a recent downturn. The Beta values hover around 0.3, indicating relatively low volatility compared to the overall market.  Note the significant MDD (Maximum Drawdown) in the recent years, highlighting significant risk.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 58.0% | 1.8% | 30.0% | 0.1 | 181.8 |
| 2016-2018  | 66.0% | 10.5% | 47.0% | 0.1 | 208.2 |
| 2017-2019  | 52.0% | 10.5% | 21.0% | 0.3 | 249.8 |
| 2018-2020  | 32.0% | 10.5% | 5.0% | 0.3 | 302.9 |
| 2019-2021  | 96.0% | 9.4% | 26.0% | 0.3 | 439.9 |
| 2020-2022  | 102.0% | 5.5% | 93.0% | 0.3 | 470.4 |
| 2021-2023  | 60.0% | 5.5% | 37.0% | 0.3 | 474.1 |
| 2022-2024  | -24.0% | 16.6% | -57.0% | 0.3 | 462.7 |
| 2023-2025  | -29.0% | 16.6% | -79.0% | 0.2 | 451.4 |


**2. Recent Price Movement:**

* **Closing Price:** $493.48
* **5-day Moving Average:** $479.77
* **20-day Moving Average:** $494.74
* **60-day Moving Average:** $513.88

The price is slightly below the 20-day moving average and significantly below the 60-day moving average, suggesting a potential downward trend.  The recent price increase (Last-market data) shows a minor positive change, but context within the larger trend is necessary.

**3. Technical Indicators & Expected Return:**

* **RSI:** 39.57 (Approaching oversold territory, but not decisively so.)
* **PPO:** 0.24 (Positive, suggesting bullish momentum, but relatively weak.)
* **20-day Relative Divergence Change:** +10.7 (Short-term upward movement.)
* **Expected Return (2+ years):** 420.5% (This is a significant figure and requires careful consideration.  The methodology used to arrive at this number needs to be reviewed for validity.  Such a high expected return implies a very optimistic outlook and carries substantial risk.)
* **Last-market change:** The small positive change is insufficient to signify a significant shift from the downward trend indicated by the moving averages.


**4. Recent Earnings Analysis:**

| Date       | EPS   | Revenue       |
|------------|-------|---------------|
| 2024-11-04 | 6.56  | $100.82 B     |
| 2024-08-09 | 4.58  | $98.86 B     |
| 2024-05-09 | -1.53 | $99.80 B     |
| 2023-11-06 | 6.31  | $92.36 B     |
| 2024-11-04 | 6.31  | $92.36 B     |

There is a duplicated entry for 2024-11-04.  Revenue is relatively stable, but EPS shows significant volatility, with a notable negative EPS in Q2 2024.  This volatility needs further investigation to understand underlying factors.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue       | Profit Margin |
|---------|---------------|---------------|
| 2024-12-31 | $100.81B     | 21.14%        |
| 2024-09-30 | $100.82B     | 22.84%        |
| 2024-06-30 | $98.86B     | 22.31%        |
| 2024-03-31 | $99.80B     | 23.05%        |
| 2023-12-31 | $94.43B     | 23.30%        |

Revenue remains relatively consistent. Profit margins are generally high and stable, though there's some fluctuation.

**Capital and Profitability:**

| Quarter | Equity        | ROE           |
|---------|---------------|---------------|
| 2024-12-31 | $92.66B      | 5.98%         |
| 2024-09-30 | $94.53B      | 6.41%         |
| 2024-06-30 | $89.36B      | 4.72%         |
| 2024-03-31 | $86.69B      | -1.63%        |
| 2023-12-31 | $88.76B      | 6.15%         |

Equity fluctuates, and ROE shows volatility, with a significant negative value in Q1 2024.  This needs further analysis to understand the cause.


**6. Overall Conclusion:**

UNH has historically shown strong performance, significantly outperforming the S&P 500.  However, recent data reveals a concerning downward trend, with negative CAGR and a high maximum drawdown.  While the high expected return is attractive, its basis needs rigorous validation. The volatility in EPS and ROE, particularly the negative ROE in Q1 2024, necessitates further investigation into the underlying factors driving these fluctuations.  Before making any investment decisions, a deeper dive into the company's financials, competitive landscape, and future prospects is crucial to assess the risk-reward profile. The current indicators suggest caution, and a thorough due diligence is warranted before investing.
